Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Shandong Luye Pharmaceutical
Shandong Luye Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Rykindo
Risperidone
2023-01-13
2025-2033
Dementia
,
Tourette syndrome
,
Schizophrenia
,
Bipolar disorder
,
Autistic disorder
,
Schizophrenia spectrum and other psychotic disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Albumin
malaria
,
drug-related side effects and adverse reactions
,
kidney diseases
,
membranous glomerulonephritis
,
nephrotic syndrome
,
nephrosis
,
dengue
,
breast neoplasms
,
overactive urinary bladder
,
herpes zoster
,
chickenpox
,
stroke
,
muscle spasticity
,
urinary incontinence
,
enuresis
,
recurrence
,
uterine cervical neoplasms
,
virus diseases
,
varicella zoster virus infection
Toludesvenlafaxine
depression
,
major depressive disorder
,
depressive disorder
Glycididazole
chemoradiotherapy
,
esophageal neoplasms
,
carcinoma
,
squamous cell carcinoma
Taxane
neoplasms
,
carcinoma
,
squamous cell carcinoma
,
esophageal squamous cell carcinoma
,
hematologic neoplasms
,
castration-resistant prostatic neoplasms
,
breast neoplasms
,
prostatic neoplasms
,
ovarian neoplasms
,
brain neoplasms
,
neoplasm metastasis
,
fallopian tube neoplasms
,
peritoneal neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use